![Birgit Schultes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Birgit Schultes
Chief Tech/Sci/R&D Officer at
INTELLIA THERAPEUTICS, INC.
Net worth: 2 M $ as of 2026-08-30
Profile
Birgit Schultes currently works at Intellia Therapeutics, Inc., as Chief Scientific Officer & Executive VP from 2025.
Dr. Schultes received her graduate degree and doctorate degree from the University of Bonn.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 124,304 ( 0.09% ) | 2 M $ | 2026-08-30 |
Birgit Schultes active positions
| Companies | Position | Start |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2025-01-12 |
Training of Birgit Schultes
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
36
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
University of Bonn
 University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
- Stock Market
- Insiders
- Birgit Schultes
